The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
105648243 10564824 3 F 20111007 20160816 20141105 20160817 EXP CA-ROCHE-1007864 ROCHE 58.29 YR F Y 61.00000 KG 20160817 OT CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
105648243 10564824 1 PS ACTEMRA TOCILIZUMAB 1 Intravenous (not otherwise specified) U 125276 488 MG SOLUTION FOR INFUSION /month
105648243 10564824 2 SS ACTEMRA TOCILIZUMAB 1 Intravenous (not otherwise specified) U 125276 SOLUTION FOR INFUSION
105648243 10564824 3 SS ACTEMRA TOCILIZUMAB 1 Intravenous (not otherwise specified) U 125276 473 MG SOLUTION FOR INFUSION
105648243 10564824 4 SS ACTEMRA TOCILIZUMAB 1 Intravenous (not otherwise specified) U 125276 490.9 MG SOLUTION FOR INFUSION
105648243 10564824 5 SS ACTEMRA TOCILIZUMAB 1 Intravenous (not otherwise specified) U 125276 483 MG SOLUTION FOR INFUSION
105648243 10564824 6 C CELEBREX CELECOXIB 1 Unknown 0 100 MG BID
105648243 10564824 7 C METHOTREXATE. METHOTREXATE 1 Oral 0 20 MG /wk
105648243 10564824 8 C FOLINIC ACID LEUCOVORIN 1 Unknown 0 5 MG /wk
105648243 10564824 9 C MEDROXYPROGESTERONE MEDROXYPROGESTERONE 1 Unknown REPORTED:APO-METROXY 0 2.5 MG QD
105648243 10564824 10 C PREMARIN ESTROGENS, CONJUGATED 1 Unknown 0 .3 MG QOD
105648243 10564824 11 C HYDROCHLOROTHIAZIDE. HYDROCHLOROTHIAZIDE 1 Unknown 0 25 MG QD
105648243 10564824 12 C NEXIUM ESOMEPRAZOLE MAGNESIUM 1 Unknown 0 40 MG QOD
105648243 10564824 13 C TYLENOL WITH CODEINE ACETAMINOPHENCODEINE PHOSPHATE 1 Unknown 0
105648243 10564824 14 C ACLASTA ZOLEDRONIC ACID 1 Unknown 0
105648243 10564824 15 C PREDNISONE. PREDNISONE 1 Unknown 0 4 MG QD
105648243 10564824 16 C PREDNISONE. PREDNISONE 1 Unknown 0 8 MG QD
105648243 10564824 17 C LEUCOVORIN CALCIUM. LEUCOVORIN CALCIUM 1 Unknown 0 5 MG /wk

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
105648243 10564824 1 Rheumatoid arthritis
105648243 10564824 11 Hypertension

Outcome of event

Event ID CASEID OUTC COD
105648243 10564824 OT
105648243 10564824 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
105648243 10564824 Fall
105648243 10564824 Femur fracture
105648243 10564824 Infected skin ulcer
105648243 10564824 Infection
105648243 10564824 Malaise
105648243 10564824 Osteomyelitis
105648243 10564824 Skin ulcer
105648243 10564824 Upper limb fracture

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
105648243 10564824 1 20110728 0
105648243 10564824 2 20121220 0
105648243 10564824 3 20130611 0
105648243 10564824 4 20140714 0
105648243 10564824 5 20160120 0
105648243 10564824 11 20090723 20110917 0
105648243 10564824 12 20111007 0
105648243 10564824 14 20110216 0